High-grade serous ovarian carcinoma organoids as models of chromosomal instability
2023
Maria Vias | Lena Morrill Gavarró | Carolin M Sauer | Deborah A Sanders | Anna M Piskorz | Dominique-Laurent Couturier | Stéphane Ballereau | Bárbara Hernando | Michael P Schneider | James Hall | Filipe Correia-Martins | Florian Markowetz | Geoff Macintyre | James D Brenton
High-grade serous ovarian carcinoma (HGSOC) is the most genomically complex cancer, characterized by ubiquitous TP53 mutation, profound chromosomal instability, and heterogeneity. The mutational processes driving chromosomal instability in HGSOC can be distinguished by specific copy number signatures. To develop clinically relevant models of these mutational processes we derived 15 continuous HGSOC patient-derived organoids (PDOs) and characterized them using bulk transcriptomic, bulk genomic, single-cell genomic, and drug sensitivity assays. We show that HGSOC PDOs comprise communities of different clonal populations and represent models of different causes of chromosomal instability including homologous recombination deficiency, chromothripsis, tandem-duplicator phenotype, and whole genome duplication. We also show that these PDOs can be used as exploratory tools to study transcriptional effects of copy number alterations as well as compound-sensitivity tests. In summary, HGSOC PDO cultures provide validated genomic models for studies of specific mutational processes and precision therapeutics.
显示更多 [+] 显示较少 [-]